Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention

Can a Selective PPARγ Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone?

(2014) Alex M. DePaoli et al.   DIABETES CARE

Type 2 diabetes mellitus and fracture risk

(2014) Anastasia D. Dede et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ

(2014) Alexander S. Banks et al.   NATURE

Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials

(2013) Matteo Monami et al.   ACTA DIABETOLOGICA

Renal aquaporins and water balance disorders

(2013) Marleen L.A. Kortenoeven et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Vasopressin and the regulation of aquaporin-2

(2013) Justin L. L. Wilson et al.   Clinical and Experimental Nephrology

In Vivo Actions of Peroxisome Proliferator-Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion

(2013) R. Eldor et al.   DIABETES CARE

The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial

(2013) Andrew Grey et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Activation of a retinoic acid receptor pathway by thiazolidinediones induces production of vascular endothelial growth factor/vascular permeability factor in OP9 adipocytes

(2013) Daisuke Kotake et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

(2013) John P. Bilezikian et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adiponectin Promotes Functional Recovery after Podocyte Ablation

(2013) J. M. Rutkowski et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Looking at nuclear receptors from a new angle

(2013) Christine Helsen et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

PPARγ signaling and metabolism: the good, the bad and the future

(2013) Maryam Ahmadian et al.   NATURE MEDICINE

Physiology and pathophysiology of SLC12A1/2 transporters

(2013) Nicolas Markadieu et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus

(2012) H. S. Chou et al.   DIABETES OBESITY & METABOLISM

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty

(2012) Janice V. Huang et al.   JOURNAL OF LIPID RESEARCH

Thiazolidinediones and PPARγ agonists: time for a reassessment

(2012) Bertrand Cariou et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Thiazolidinediones Enhance Sodium-Coupled Bicarbonate Absorption from Renal Proximal Tubules via PPARγ-Dependent Nongenomic Signaling

(2011) Yoko Endo et al.   Cell Metabolism

PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases

(2011) Jichun Yang et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

(2011) Ralph A. DeFronzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mechanisms of cell polarity and aquaporin sorting in the nephron

(2011) Bayram Edemir et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

PPAR-γ Agonism for Cardiovascular and Renal Protection

(2010) Pantelis A. Sarafidis et al.   Cardiovascular Therapeutics

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5

(2010) Jang Hyun Choi et al.   NATURE

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

(2009) R. A. DeFronzo   DIABETES

Thiazolidinedione-Induced Fluid Retention Is Independent of Collecting Duct  ENaC Activity

(2009) V. Vallon et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Fat and Beyond: The Diverse Biology of PPARγ

(2008) Peter Tontonoz et al.   Annual Review of Biochemistry

Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients

(2008) Y. Miyazaki et al.   DIABETES OBESITY & METABOLISM

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

(2008) G. J. Ko et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

PPARγand MEK Interactions in Cancer

(2008) Elke Burgermeister et al.   PPAR Research

Roles of ERK and cPLA2 in the Angiotensin II-Mediated Biphasic Regulation of Na+-HCO3- Transport

(2007) Y. Li et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY